Cargando…

Anti-inflammatory role of fenofibrate in treating diseases

Inflammation contributes to the pathogenesis of several diseases. Fenofibrate, known as a peroxisome proliferator-activated receptor-α (PPAR-α) agonist, is a classic drug for treating hyperlipidemia. In addition to its lipid-lowering effect, fenofibrate has also been reported to exert anti-inflammat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Lv, Hua, Hu, Ji, Yong, Jia, Zhanjun, Peng, Mingqi, Huang, Songming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171448/ https://www.ncbi.nlm.nih.gov/pubmed/36724021 http://dx.doi.org/10.17305/bb.2022.8534

Ejemplares similares

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013)

Reduction of NADPH oxidase 4 in adipocytes contributes to the anti-obesity effect of dihydroartemisinin
por: Hua, Hu, et al.
Publicado: (2023)

A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy
por: Strain, Joe D, et al.
Publicado: (2010)

Role of COX-2/mPGES-1/Prostaglandin E2 Cascade in Kidney Injury
por: Jia, Zhanjun, et al.
Publicado: (2015)

The role of fenofibrate in the treatment of COVID-19
por: Yasmin, Farah, et al.
Publicado: (2021)

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients
por: Ju, Hai-Bing, et al.
Publicado: (2017)

Roles of EP Receptors in the Regulation of Fluid Balance and Blood Pressure
por: Wang, Lu, et al.
Publicado: (2022)

Prostaglandins in the pathogenesis of kidney diseases
por: Li, Yuanyuan, et al.
Publicado: (2018)

Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases
por: Yang, Shih-Chun, et al.
Publicado: (2022)

Fenofibrate-induced renal dysfunction, yes or no?
por: Emami, Fatemeh, et al.
Publicado: (2020)

Anticancer Properties of Fenofibrate: A Repurposing Use
por: Lian, Xin, et al.
Publicado: (2018)

The spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritis
por: Chin, Kok-Yong
Publicado: (2016)

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
por: Moutzouri, Elisavet, et al.
Publicado: (2010)

Indirect Neonatal Hyperbilirubinemia and the Role of Fenofibrate as an Adjuvant to Phototherapy
por: Shabo, Salam K., et al.
Publicado: (2023)

Anti-Inflammatory Mechanisms of Fucoidans to Treat Inflammatory Diseases: A Review
por: Sanjeewa, Kalu K. Asanka, et al.
Publicado: (2021)

A Potential Therapy Using Antisense Oligonucleotides to Treat Autosomal Recessive Polycystic Kidney Disease
por: Li, Huixia, et al.
Publicado: (2023)

Fibrane the reduced derivative of fenofibrate
por: Kotheimer, Amanda E., et al.
Publicado: (2019)

Protective role of fenofibrate in sepsis-induced acute kidney injury in BALB/c mice
por: Pei, Zuowei, et al.
Publicado: (2018)

PGC-1α overexpression protects against aldosterone-induced podocyte depletion: role of mitochondria
por: Zhao, Min, et al.
Publicado: (2016)

Inhibition of Mitochondrial Complex-1 Prevents the Downregulation of NKCC2 and ENaCα in Obstructive Kidney Disease
por: Zhang, Yue, et al.
Publicado: (2015)

Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice
por: Finch, Emily R., et al.
Publicado: (2020)

Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population
por: Patel, Piyush, et al.
Publicado: (2016)

Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin
por: Ginwala, Rashida, et al.
Publicado: (2019)

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia
por: Sun, Bing, et al.
Publicado: (2015)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
por: Jia, Zhanjun, et al.
Publicado: (2014)

Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models
por: Mahmoudi, Ali, et al.
Publicado: (2022)

Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011)

Detecting responses to treatment with fenofibrate in pedigrees
por: Cherlin, Svetlana, et al.
Publicado: (2018)

Effect of Fenofibrate Medication on Renal Function
por: Kim, Sungjong, et al.
Publicado: (2017)

The Role of Akt2 in the Protective Effect of Fenofibrate against Diabetic Nephropathy
por: Cheng, Yanli, et al.
Publicado: (2020)

TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate
por: Kabagambe, Edmond K, et al.
Publicado: (2009)

Fenofibrate modified-release pellets with lag phase and high oral bioavailability
por: Li, Fang, et al.
Publicado: (2018)

Fenofibrate decreased microalbuminuria in the type 2 diabetes patients with hypertriglyceridemia
por: Sun, Xiaomeng, et al.
Publicado: (2020)

Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC
por: Pieralisi, Azul V., et al.
Publicado: (2022)

Role of nuclear receptor PXR in immune cells and inflammatory diseases
por: Sun, Le, et al.
Publicado: (2022)

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]
Publicado: (2005)

Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review
por: Tziomalos, Konstantinos, et al.
Publicado: (2006)

Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing
por: Farnier, Michel
Publicado: (2008)

Celastrol inhibits intestinal lipid absorption by reprofiling the gut microbiota to attenuate high-fat diet-induced obesity
por: Hua, Hu, et al.
Publicado: (2021)

Fenofibrate: direct attenuating effects on tumor growth
por: Kapoor, Shailendra
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1ortkc0ekik4frp6r9eiuevdgj